arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

CorMedix Inc.

CRMD Health Care Biotechnology: Pharmaceutical Preparations
$7.85
▲ +0.8% Today
as of Oct 23, 16:47 ET
Last 30 days -0.51% Sep 14 → Oct 23
$7.12 $7.38 $7.65 $7.91 $8.17 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$8.01
High
$8.11
Low
$7.79
Volume
$894,232
Avg Vol
$2M
Mkt Cap
$578M
P/E (TTM)
3.67
Beta
—
52w High
$13.02
52w Low
$6.13
Div Yield
—
Shares Out
$78M

Recent Press Releases & News last 60 days · 8 items

Oct 19 · 12:48 MT Newswires
CorMedix Receives FDA Priority Review for Rezzayo Fungal Disease Prevention
Oct 19 · 11:30 PR GlobeNewswire
Cormedix Announces FDA Acceptance for Priority Review of Supplemental NDA for Rezzayo® (Rezafungin) for Prophylaxis of Invasive Fungal Diseases
Oct 8 · 14:40 Zacks
CRMD vs. PRTA: Which Stock Should Value Investors Buy Now?
▸ Show all 8 press releases & news Free account →

CRMD earnings at a glance

The options market is pricing a move of about ±8.2% after the report, a range of roughly $7.21 to $8.49 from today's $7.85. Over its last 2 reports the stock rose the next day 2 times and fell 0, moving ±14.7% on average; after the most recent report on May 14, 2026 it moved +5.7%. That means options currently expect less movement than CRMD has typically delivered. CRMD beat the consensus EPS estimate in 4 of its last 4 reported quarters. Implied volatility is currently 69%. The share price of $7.85 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$6.13
$13
25% of range
Avg surprise (last 4)
+25.4%
Avg reaction (last 2)
+14.7%
100% positive
Latest IV / EM
69%
EM ±8.2% · $7 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.25$-0.05$0.16$0.36$0.57 Actual $-0.24Actual $-0.25Actual $-0.17Actual $-0.25Actual $-0.25Actual $-0.05Actual $0.30Est $0.25Actual $0.28Est $0.20Actual $0.57Est $0.48Actual $0.43Est $0.35Actual $0.29 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-3M$31M$66M$100M$134M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $0.29 — — — — financials
Thu May 14, 2026Mar/2026 $0.43 $0.35 +22.9% +43.3% +5.7% earnings
Wed Nov 12, 2025Sep/2025 $0.57 $0.48 +18.8% — — earnings
Thu Aug 7, 2025Jun/2025 $0.28 $0.20 +40.0% — — earnings
Tue May 6, 2025Mar/2025 $0.30 $0.25 +20.0% — +23.6% earnings
Mon Sep 30, 2024Sep 2024 $-0.05 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.25 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.25 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.17 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.25 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.24 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$102M$127M—$104M$40M$39M—$11M
Cost of revenue—$12M—$8M$2M$2M—$634,650
Gross profit$77M$105M—$93M$38M$37M—$11M
Operating income$43M$64M—$51M$20M$20M—$-3M
Net income$26M$39M—$109M$20M$21M—$-3M
EPS (diluted)$0.29$0.43—$1.26$0.28$0.30—$-0.05

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$257M$178M$145M$48M$159M$66M$41M$35M
Inventory$39M$31M$30M$29M$10M$7M$8M$7M
Total current assets$481M$383M$367M$260M$248M$145M$115M$73M
Total assets$904M$816M$826M$751M$253M$150M$119M$78M
Long-term debt————————
Total liabilities$443M$379M$421M$377M$32M$35M$34M$19M
Total equity$461M$437M$405M$374M$221M$115M$85M$59M

Implied volatility — last 90 days

13%62%111%160%209% Jun 07 — IV 95% · EM ±13.2%Jun 08 — IV 71% · EM ±9.4%Jun 09 — IV 62% · EM ±7.8%Jun 10 — IV 58% · EM ±6.8%Jun 11 — IV 58% · EM ±6.4%Jun 12 — IV 58% · EM ±5.9%Jun 15 — IV 109% · EM ±7.9%Jun 16 — IV 158% · EM ±9.3%Jun 17 — IV 207% · EM ±8.7%Jun 19 — IV 50% · EM ±11.0%Jun 22 — IV 43% · EM ±9.1%Jun 23 — IV 42% · EM ±8.6%Jun 24 — IV 39% · EM ±7.8%Jun 25 — IV 55% · EM ±10.7%Jun 26 — IV 53% · EM ±10.2%Jun 29 — IV 57% · EM ±10.1%Jun 30 — IV 47% · EM ±8.0%Jul 01 — IV 88% · EM ±14.8%Jul 02 — IV 64% · EM ±10.3%Jul 03 — IV 66% · EM ±10.3%Jul 07 — IV 30% · EM ±3.9%Jul 08 — IV 86% · EM ±10.8%Jul 10 — IV 73% · EM ±8.0%Jul 13 — IV 83% · EM ±6.9%Jul 14 — IV 158% · EM ±11.4%Jul 15 — IV 111% · EM ±6.5%Jul 20 — IV 86% · EM ±20.2%Jul 21 — IV 77% · EM ±18.0%Jul 22 — IV 63% · EM ±14.5%Jul 23 — IV 75% · EM ±16.8%Jul 24 — IV 78% · EM ±17.2%Jul 27 — IV 76% · EM ±15.9%Jul 28 — IV 75% · EM ±15.3%Jul 29 — IV 59% · EM ±11.8%Jul 30 — IV 78% · EM ±15.4%Jul 31 — IV 83% · EM ±15.9%Aug 03 — IV 99% · EM ±17.6%Aug 04 — IV 131% · EM ±22.6%Aug 05 — IV 158% · EM ±26.3%Aug 06 — IV 93% · EM ±15.0%Aug 07 — IV 125% · EM ±19.5%Aug 10 — IV 115% · EM ±15.9%Aug 11 — IV 112% · EM ±14.8%Aug 12 — IV 169% · EM ±21.1%Aug 13 — IV 77% · EM ±9.1%Aug 14 — IV 74% · EM ±8.2%Aug 17 — IV 117% · EM ±9.8%Aug 18 — IV 84% · EM ±6.1%Aug 19 — IV 209% · EM ±12.4%Aug 20 — IV 160% · EM ±6.7%Aug 24 — IV 40% · EM ±8.5%Aug 25 — IV 37% · EM ±7.6%Aug 26 — IV 52% · EM ±10.4%Aug 27 — IV 51% · EM ±9.9%Aug 28 — IV 30% · EM ±5.7%Aug 31 — IV 38% · EM ±6.7%Sep 01 — IV 49% · EM ±8.4%Sep 02 — IV 14% · EM ±2.3%Sep 03 — IV 50% · EM ±8.1%Sep 04 — IV 72% · EM ±11.3%Sep 07 — IV 81% · EM ±11.3%Sep 08 — IV 50% · EM ±6.7%Sep 09 — IV 39% · EM ±4.9%Sep 10 — IV 53% · EM ±6.3%Sep 11 — IV 29% · EM ±3.2%Sep 14 — IV 99% · EM ±8.2%Sep 21 — IV 40% · EM ±8.4%Sep 22 — IV 35% · EM ±7.1%Sep 23 — IV 52% · EM ±10.4%Sep 24 — IV 56% · EM ±10.9%Sep 25 — IV 40% · EM ±7.6%Sep 28 — IV 43% · EM ±7.6%Sep 29 — IV 46% · EM ±7.9%Sep 30 — IV 51% · EM ±8.4%Oct 01 — IV 104% · EM ±16.8%Oct 06 — IV 83% · EM ±11.0%Oct 07 — IV 66% · EM ±8.2%Oct 08 — IV 69% · EM ±8.2%

Sector peers

SGMT
Sagimet Biosciences Inc.
$577M $9.58-4.1%
STTK
Shattuck Labs, Inc.
$568M $5.49-1.6%
CTMX
CytomX Therapeutics, Inc.
$556M $2.32-3.3%
CLYM
Climb Bio, Inc.
$615M $10.19-6.3%
IRWD
Ironwood Pharmaceuticals, Inc.
$621M $3.46-2.5%
CAPR
Capricor Therapeutics, Inc.
$520M $5.93+0.8%

CRMD earnings FAQ

What is CRMD's expected move for earnings?

Options currently price a move of about ±8.2%, or $0.64 per share either way from $7.85.

How does CRMD stock usually react to earnings?

Across the last 2 reports the average next-day move was ±14.7%, up 2 times and down 0 times.

What is CRMD's implied volatility?

CRMD's at-the-money implied volatility is about 69% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in